Patents Assigned to Baylor
  • Patent number: 10761067
    Abstract: Embodiments are disclosed for characterizing and quantifying composite laminate structures, including structures with surfaces that are curved in two and three dimensions. The embodiments take a composite laminate of unknown ply stack composition and sequence and determine various information about the individual plies, such as ply stack, orientation, microstructure, and type. The embodiments can distinguish between weave types that may exhibit similar planar stiffness behaviors, but would produce different failure mechanisms. Individual ply information may then be used to derive the laminate bulk properties from externally provided constitutive properties of the fiber and matrix, including extensional stiffness, bending-extension coupling stiffness, bending stiffness, and the like. The laminate bulk properties may then be used to generate a probabilistic failure envelope for the composite laminate.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: September 1, 2020
    Assignee: Baylor University
    Inventors: David A. Jack, John E. Fitch, Theresa Vo, Caleb Heimsoth, Sarah Stair
  • Patent number: 10758551
    Abstract: It was discovered that NF-?B signaling pathway plays a central role in pancreatitis, and inhibition of NF-?B signaling has the potential to reduce the incidence of pancreatitis and protect pancreatic tissues from inflammatory damage. Aspects of the disclosure relate to a method for inhibiting or treating pancreatitis in a subject in need thereof comprising administering a therapeutically effective amount of an NF-?B signaling pathway inhibitor to the subject.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: September 1, 2020
    Assignee: Baylor Research Institute
    Inventors: Mazhar Adnan Kanak, Bashoo Naziruddin, Marlon F. Levy
  • Publication number: 20200258442
    Abstract: Systems and methods for a six-primary color system for display. A six-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. The six-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
    Type: Application
    Filed: April 28, 2020
    Publication date: August 13, 2020
    Applicant: Baylor University
    Inventors: Gary B. Mandle, James M. DeFilippis
  • Publication number: 20200251039
    Abstract: Systems and methods for a six-primary color system for display. A six-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. The six-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
    Type: Application
    Filed: April 20, 2020
    Publication date: August 6, 2020
    Applicant: Baylor University
    Inventors: Gary B. Mandle, James M. DeFilippis
  • Patent number: 10722572
    Abstract: Methods and compositions are provided that can be used to vaccinate against and treat HIV. Specifically contemplated are vaccine compositions and methods of using these compositions treat HIV in patients. Aspects of the disclosure relate to an anti-CD40 antibody-HIV antigen fusion protein comprising (i) an anti-CD40 heavy chain (HCD40)-HIV antigen (Ag) fusion protein comprising the formula: HCD40-Ag, wherein Ag is a polypeptide with at least 80% sequence identity to SEQ ID NO:1; and (ii) an anti-CD40 light chain (LCD40).
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: July 28, 2020
    Assignees: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE INSERM, UNIVERSITE PARIS EST CRETEIL VAL DE MARNE, BAYLOR RESEARCH INSTITUTE, ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
    Inventors: Yves Levy, Gerard Zurawski, Sandra Zurawski, Anne-Laure Flamar
  • Patent number: 10716832
    Abstract: The present invention includes compositions and methods for treating arthritic joints found in patients with autoinflammation, e.g., systemic onset juvenile idiopathic arthritis, by administering at the site of inflammation a therapeutically effective amount of at least one agent that reduces or blocks the bioavailability of interleukin-1?.
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: July 21, 2020
    Assignee: Baylor Research Institute
    Inventors: Jacques F. Banchereau, Maria Virginia Pascual
  • Patent number: 10716818
    Abstract: The present disclosure concerns combination therapy for cancer that utilizes (i) an oncolytic virus; (ii) a virus comprising nucleic acid encoding an immunomodulatory factor, and (iii) at least one cell comprising a chimeric antigen receptor (CAR) specific for a cancer cell antigen. In particular embodiments, the virus comprises nucleic acid encoding an immunomodulatory factor comprises nucleic acid encoding IL-12 and/or antagonist anti-PD-L1 antibody.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: July 21, 2020
    Assignee: Baylor College of Medicine
    Inventors: Masataka Suzuki, Amanda Rosewell Shaw, Caroline Elaine Porter, Norihiro Watanabe, Malcolm K. Brenner
  • Publication number: 20200222453
    Abstract: Modified hydrophilic carbon clusters (HCCs), poly(ethylene glycol)-hydrophilic carbon clusters (PEG-HCCs) and similarly structured materials like graphene quantum dots (GQDs), PEGylated GQDs, small molecule antioxidants, and PEGylated small molecule antioxidants. These materials have been modified with an iron chelating moiety, deferoxamine, or a similar chelating moiety. By exploiting common binding sites, the carbon nanostructure facilitates intracellular transport including in mitochondria, reduces oxidative breakdown of the chelator moiety prior to treatment, and reduces both the cause and consequences of metal induced oxidative stress within the body thus providing a novel form of therapy for a range of oxidative and metal-related toxicities. Graphenic materials can be used for the treatment of acute and chronic mitochondrial electron transport chain dysfunction.
    Type: Application
    Filed: April 30, 2018
    Publication date: July 16, 2020
    Applicants: WILLIAM MARSH RICE UNIVERSITY, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, BAYLOR COLLEGE OF MEDICINE, HOUSTON METHODIST RESEARCH INSTITUTE, THE UNITED STATES GOVERNMENT
    Inventors: James M. TOUR, Lizanne NILEWSKI, William SIKKEMA, Kimberly MENDOZA, Thomas Andrew KENT, William DALMEIDA, Jr., Paul J. DERRY, Ah-Lim TSAI, Muralidhar L. HEGDE, Prakash DHARMALINGAM, Pavana Dixit HEGDE, Sankar MITRA, Joy MITRA
  • Publication number: 20200226967
    Abstract: Systems and methods for a six-primary color system for display. A six-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. The six-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
    Type: Application
    Filed: March 26, 2020
    Publication date: July 16, 2020
    Applicant: Baylor University
    Inventor: Gary B. Mandle
  • Publication number: 20200216810
    Abstract: An isolated human NKT cell or a plurality of cells thereof, having reduced or no detectable expression of endogenous beta-2-microglobulin (B2M); endogenous MHC class II-associated invariant chain (Ii); or both. Methods to generate the cell or cells, and methods of treatment using the cell or cells are also provided.
    Type: Application
    Filed: August 10, 2018
    Publication date: July 9, 2020
    Applicant: Baylor College of Medicine
    Inventors: Leonid S. Metelitsa, Jingling Jin, Bin Liu
  • Publication number: 20200209261
    Abstract: Embodiments of the disclosure include systems, methods, and compositions for detection of imminent onset of a symptom of a gut inflammation medical condition. The disclosure also concerns microbial biosensors that detect a marker in the gut that is predictive of onset of at least one symptom of inflammatory bowel disease (IBD), for example, and such a sensor may include a promoter sensitive to the marker that is linked to expression of a detectable readout, such as in the feces of the individual with IBD.
    Type: Application
    Filed: May 11, 2018
    Publication date: July 2, 2020
    Applicant: Baylor College of Medicine
    Inventors: Robert Allen Britton, Jeffrey David Galley
  • Patent number: 10695401
    Abstract: Embodiments of the disclosure include methods and compositions for treating or preventing acute inflammation using soluble vimentin. In specific embodiments, a vimentin derivative comprising the rod domain is utilized for treating or preventing any disease in which a decrease in leukocyte adhesion is therapeutic. In specific embodiments, a fragment of vimentin that comprises part or all of the rod domain is employed.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: June 30, 2020
    Assignee: Baylor College of Medicine
    Inventors: Fong Wilson Lam, Qi Da, Miguel A. Cruz
  • Patent number: 10697941
    Abstract: Method and system are disclosed for characterizing and quantifying composite laminate structures. The method and system take a composite laminate of unknown ply stack composition and sequence and determine various information about the individual plies, such as ply stack, orientation, microstructure, and type. The method and system can distinguish between weave types that may exhibit similar planar stiffness behaviors, but would produce different failure mechanisms. Individual ply information may then be used to derive the laminate bulk properties from externally provided constitutive properties of the fiber and matrix, including extensional stiffness, bending-extension coupling stiffness, bending stiffness, and the like. The laminate bulk properties may then be used to generate a probabilistic failure envelope for the composite laminate.
    Type: Grant
    Filed: March 20, 2013
    Date of Patent: June 30, 2020
    Assignee: BAYLOR UNIVERSITY
    Inventors: David A. Jack, John E. Fitch, Theresa Vo
  • Patent number: 10698134
    Abstract: The present disclosure provides a system and method for a tunable ENZ material that can vary the absorption of radiant energy. The tunable ENZ material can act as a broadband absorber advantageously using a stack of ultrathin conducting layers having an epsilon-near-zero (ENZ) regime of permittivity at different wavelengths. The conducting materials can include at least partially transparent conducting oxide or transition metal nitride layers with different electron concentrations and hence different ENZ frequencies for a broadband range of energy absorption. The layer(s) can be directly tuned to various frequencies to achieve high levels of absorption at deep subwavelength ENZ thicknesses. An applied electric bias can create electron accumulation/depletion regions in an ENZ semiconductor device and allows control of plasma frequency and hence high levels of absorption in the device. Further, for a stack of layers, the carrier concentration can be altered from layer to layer.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: June 30, 2020
    Assignee: Baylor University
    Inventors: Oleksiy Anopchenko, Ho Wai Howard Lee
  • Patent number: 10683361
    Abstract: The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccine and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: June 16, 2020
    Assignee: Baylor Research Institute
    Inventors: Jacques F. Banchereau, Gerard Zurawski, Sandra Zurawski, SangKon Oh
  • Patent number: 10676455
    Abstract: Embodiments of the invention include methods of treating, preventing, and/or reduce the risk or severity of a condition selected from the group consisting of muscle wasting, muscle weakness, cachexia, and a combination thereof in an individual in need thereof. In some embodiments, particular small molecules are employed for treatment, prevention, and/or reduction in the risk of muscle wasting. In at least particular cases, the small molecules are inhibitors of STAT3.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: June 9, 2020
    Assignee: Baylor College of Medicine
    Inventors: David J. Tweardy, Moses M. Kasembeli, Marvin X. Xu, Thomas Kristian Eckols
  • Patent number: 10643828
    Abstract: The present disclosure provides a system and method for mass spectrometry imaging in a multi-stage ionization applying different technologies by decoupling the desorption and ionization events. At a first stage, a primary beam, such as an ion beam, desorbs one or more molecules of a targeted sample, and at a second stage the desorbed molecules are ionized. The system and method can act independent of a matrix application to the target sample for a direct analysis and has the spatial resolution needed to operate in nano-meters resolution for a cell-by-cell analysis, if desired. The first stage desorption applies a first technique that allows neutral molecules of the target sample to become desorbed from the surface without requiring the molecules to be ionized during the desorption. The second stage ionizes the neutral molecules after the desorption in the first stage, when the defined target molecules have been volatilized.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: May 5, 2020
    Assignee: Baylor University
    Inventor: Touradj Solouki
  • Patent number: 10610585
    Abstract: Methods and compositions are provided that can be used to vaccinate against and treat HIV. Specifically contemplated are vaccine compositions and methods of using these compositions treat HIV in patients. Aspects of the disclosure relate to an anti-CD40 antibody-HIV antigen fusion protein comprising (i) an anti-CD40 heavy chain (HCD40)-HIV antigen (Ag) fusion protein comprising the formula: HCD40-Ag, wherein Ag is a polypeptide with at least 80% sequence identity to SEQ ID NO:1; and (ii) an anti-CD40 light chain (LCD40).
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: April 7, 2020
    Assignees: INSERM (Institut National de la Sante et de la Recherche Medicale), Baylor Research Institute, Universite Paris Est Creteil Val De Marne, Assistance Publique Hopitaux de Paris
    Inventors: Yves Levy, Gerard Zurawski, Sandra Zurawski, Anne-Laure Flamar
  • Patent number: 10607527
    Abstract: Systems and methods for a six-primary color system for display. A six-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. The six-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: March 31, 2020
    Assignee: BAYLOR UNIVERSITY
    Inventor: Gary B. Mandle
  • Patent number: 10595742
    Abstract: A system and method for classifying body activities through an on-body antenna measuring changes in reflected power and the resulting reflection coefficients, in contrast to two antenna systems that measure transmission power therebetween. A single on-body antenna can be attached or held in close proximity to the body. The antenna can be calibrated based on changes in the reflection coefficients for various calibration activities for the location at which the antenna is placed on the body. Magnitude changes and patterns of the reflection coefficients at a given frequency for a given activity can be compared with calibrated data to correlate a given activity. Further accuracy can be gained by comparing both magnitude and phase changes and patterns at a given frequency with calibrated data for a given activity. The antenna can use power losses from a transmitted signal to measure the changes in the reflected power to minimize power requirements.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: March 24, 2020
    Assignee: Baylor University
    Inventors: Yang Li, Youngwook Kim